The aim of this study is to evaluate the efficacy of oral administration of synbiotic tablets on the clinical parameters and the levels of selected inflammatory mediators in gingival crevicular fluid (GCF) in smokers and non-smokers with gingivitis. This study designed as a double-blind randomized placebo-controlled clinical trial.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from Baseline Interleukin (IL)-6 level of GCF at 2 months
Timeframe: baseline, 1st and 2nd months
Change from Baseline IL-8 level of GCF at 2 months
Timeframe: baseline, 1st and 2nd months
Change from Baseline IL-10 level of GCF at 2 months
Timeframe: baseline, 1st and 2nd months